Inspired by Prellis
Lydia Hoo, Human Resources Manager
Lydia Hoo, Prellis’ Human Resources Manager, sits down with Tess Remick, Prellis’ Marketing Intern, to give us a bit of insight into some of her thoughts, hopes, and dreams for our company’s future.
When you first learned about Prellis Biologics and the vision of the company, what were some of your initial thoughts?
“I’ve been in bio-tech for many years; I’ve been with small biotech companies and large pharmaceutical companies, so I wasn’t new to the industry. However, I was definitely new to what Prellis is doing. When I look back on everything, I’m really amazed at what Melanie has accomplished and what her vision is. The work we do is kind of mind-boggling. As a Human Resources Manager and not a scientist, I think that the technology we use on a daily basis is really cool. The medical field has made big strides, but to have a vision of building organs—it’s something that is truly spectacular.”
When you reflect on your team at Prellis, does anything stand out to you as being really unique?
“Yes, everybody. Each person I work with cares so much about what they do. They are a wonderful group of people, they’re fun to work with, and they’re so bright. Everybody takes the time to explain what they’re working on and really make us feel like a team, so I think that says a lot. Greg [Sr. Manager Business Development] and I go way back. We’re a small enough company where there’s really that opportunity for us to get to know one another. Before COVID-19 hit, we ate lunch together daily and had a great office dynamic. Working from home, that’s the real downside to this situation.”
What excites you most about the company’s future?
“That we are actually able to 3D bioprint organs and transplant them into people that need them. I mean, I know it’s a long way off, but, we have the most intelligent team, so it could be sooner than we realize. That’s my big hope—that we can change the lives of everybody that needs an organ, instead of waiting unimaginable lengths of time like the old-fashioned way of organ-transplantation. This way, we can reach more people at a faster speed. That’s my biggest hope for Prellis and patients in the future.”